这是一篇来自已证抗体库的有关人类 TOP2A的综述,是根据26篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TOP2A 抗体。
TOP2A 同义词: TOP2; TP2A; DNA topoisomerase 2-alpha; DNA gyrase; DNA topoisomerase (ATP-hydrolyzing); DNA topoisomerase II, 170 kD; DNA topoisomerase II, alpha isozyme; topoisomerase (DNA) II alpha 170kDa

艾博抗(上海)贸易有限公司
兔 单克隆(EP1102Y)
  • 免疫印迹; 人类; 图 s10c
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, EP1102Y)被用于被用于免疫印迹在人类样品上 (图 s10c). Oncogene (2017) ncbi
兔 单克隆(EP1102Y)
  • 免疫印迹; 人类; 1:3000; 图 6b
  • 免疫沉淀; 小鼠; 图 7d
  • 免疫印迹; 小鼠; 1:3000; 图 6a
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab52934)被用于被用于免疫印迹在人类样品上浓度为1:3000 (图 6b), 被用于免疫沉淀在小鼠样品上 (图 7d) 和 被用于免疫印迹在小鼠样品上浓度为1:3000 (图 6a). Nat Commun (2016) ncbi
兔 单克隆(EP1102Y)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 8c
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 8a
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab52934)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图 8c) 和 被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图 8a). BMC Cancer (2016) ncbi
兔 单克隆(EP1102Y)
  • 免疫细胞化学; 小鼠; 1:100; 图 1b
  • 免疫印迹; 小鼠; 图 1e
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab52934)被用于被用于免疫细胞化学在小鼠样品上浓度为1:100 (图 1b) 和 被用于免疫印迹在小鼠样品上 (图 1e). Cell Signal (2016) ncbi
兔 单克隆(EPR5377)
  • 免疫印迹; 人类; 1:1000; 图 3a
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab109524)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3a). Oncotarget (2016) ncbi
兔 多克隆
  • 染色质免疫沉淀 ; 人类; 图 2d
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab12318)被用于被用于染色质免疫沉淀 在人类样品上 (图 2d) 和 被用于免疫印迹在人类样品上 (图 2c). PLoS ONE (2015) ncbi
兔 单克隆(EPR5377)
  • 免疫细胞化学; 小鼠; 1:200; 图 2
艾博抗(上海)贸易有限公司 TOP2A抗体(Epitomics, 3747-1)被用于被用于免疫细胞化学在小鼠样品上浓度为1:200 (图 2). Nat Commun (2015) ncbi
兔 单克隆(EP1102Y)
  • 染色质免疫沉淀 ; 小鼠
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab52934)被用于被用于染色质免疫沉淀 在小鼠样品上. Cell Cycle (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab12318)被用于被用于免疫印迹在人类样品上. Mol Biol Rep (2013) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠
艾博抗(上海)贸易有限公司 TOP2A抗体(Abcam, ab12318)被用于被用于免疫细胞化学在小鼠样品上. Nucleic Acids Res (2013) ncbi
赛默飞世尔
小鼠 单克隆(Ki-S1)
  • 免疫组化; 人类; 表 1
赛默飞世尔 TOP2A抗体(Thermo Fisher Scientific, Ki-S1)被用于被用于免疫组化在人类样品上 (表 1). Oncotarget (2017) ncbi
小鼠 单克隆(Ki-S1)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 TOP2A抗体(Lab Vision, Ki-s1)被用于被用于免疫组化-石蜡切片在人类样品上. Pathol Oncol Res (2015) ncbi
小鼠 单克隆(Ki-S1)
  • 免疫组化; 人类
赛默飞世尔 TOP2A抗体(Labvision, MS-1819-R7)被用于被用于免疫组化在人类样品上. Appl Immunohistochem Mol Morphol (2016) ncbi
小鼠 单克隆(Ki-S1)
  • 免疫组化-石蜡切片; 人类; 1:400
赛默飞世尔 TOP2A抗体(Thermo Lab Vision, Ki-S1)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400. Virchows Arch (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(A-8)
  • 免疫组化; 人类; 图 1a
圣克鲁斯生物技术 TOP2A抗体(Santa Cruz, sc-165986)被用于被用于免疫组化在人类样品上 (图 1a). Oncogene (2018) ncbi
小鼠 单克隆(G-6)
  • 流式细胞仪; 人类; 图 4
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 TOP2A抗体(Santa Cruz, sc-166934)被用于被用于流式细胞仪在人类样品上 (图 4) 和 被用于免疫印迹在人类样品上 (图 4). Mol Med Rep (2015) ncbi
小鼠 单克隆(F-12)
  • 免疫组化; 小鼠; 图 3
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 TOP2A抗体(Santa Cruz, sc-365916)被用于被用于免疫组化在小鼠样品上 (图 3) 和 被用于免疫印迹在小鼠样品上 (图 3). Nucleic Acids Res (2014) ncbi
Bethyl
兔 多克隆
  • 免疫印迹; 人类; 图 1b
Bethyl TOP2A抗体(Bethyl, A300-054A)被用于被用于免疫印迹在人类样品上 (图 1b). Nucleic Acids Res (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5
Bethyl TOP2A抗体(Bethyl, A300-054A)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5). Nat Chem Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
Bethyl TOP2A抗体(Bethyl Laboratories, A300-054A)被用于被用于免疫印迹在人类样品上. Biol Open (2015) ncbi
兔 多克隆
  • 免疫沉淀; 人类
Bethyl TOP2A抗体(Bethyl, A300-054A-1)被用于被用于免疫沉淀在人类样品上. J Cell Sci (2015) ncbi
武汉三鹰
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 图 1
  • 免疫印迹; 人类; 1:200; 图 5
武汉三鹰 TOP2A抗体(Proteintech, 20233-1-AP)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1) 和 被用于免疫印迹在人类样品上浓度为1:200 (图 5). Mol Med Rep (2015) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(Ki-S1)
  • 免疫印迹; 人类; 图 2
丹科医疗器械技术服务(上海)有限公司 TOP2A抗体(DAKO, Ki-S1)被用于被用于免疫印迹在人类样品上 (图 2). Cell Death Differ (2014) ncbi
碧迪BD
小鼠 单克隆(40/Topo II)
  • 免疫印迹; 小鼠; 图 3
碧迪BD TOP2A抗体(BD Pharmingen, 611492)被用于被用于免疫印迹在小鼠样品上 (图 3). Cell Death Differ (2016) ncbi
小鼠 单克隆(40/Topo II)
  • 免疫印迹; 人类; 1:1000; 图 7
碧迪BD TOP2A抗体(BD Transduction Labs, 611493)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 7). Cancers (Basel) (2015) ncbi
小鼠 单克隆(31/Topo IIa)
  • 酶联免疫吸附测定; 人类; 1:500
碧迪BD TOP2A抗体(BD Transduction Laboratories, 611326)被用于被用于酶联免疫吸附测定在人类样品上浓度为1:500. Nucleic Acids Res (2014) ncbi
文章列表
  1. Fielding A, Concannon M, Darling S, Rusilowicz Jones E, Sacco J, Prior I, et al. The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity. Oncogene. 2018;37:2326-2342 pubmed 出版商
  2. Senturk J, Bohlman S, Manfredi J. Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53. Oncogene. 2017;36:6085-6096 pubmed 出版商
  3. Ahmad M, Shen W, Li W, Xue Y, Zou S, Xu D, et al. Topoisomerase 3? is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction. Nucleic Acids Res. 2017;45:2704-2713 pubmed 出版商
  4. Gerber T, Willscher E, Loeffler Wirth H, Hopp L, Schadendorf D, Schartl M, et al. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq. Oncotarget. 2017;8:846-862 pubmed 出版商
  5. Guturi K, Bohgaki M, Bohgaki T, Srikumar T, Ng D, Kumareswaran R, et al. RNF168 and USP10 regulate topoisomerase II? function via opposing effects on its ubiquitylation. Nat Commun. 2016;7:12638 pubmed 出版商
  6. Stefansdottir A, Johnston Z, Powles Glover N, Anderson R, Adams I, Spears N. Etoposide damages female germ cells in the developing ovary. BMC Cancer. 2016;16:482 pubmed 出版商
  7. Jacobsen R, Mazloumi Gavgani F, Mellgren G, Lewis A. DNA Topoisomerase II? contributes to the early steps of adipogenesis in 3T3-L1 cells. Cell Signal. 2016;28:1593-603 pubmed 出版商
  8. Morris J, Moseley V, Cabang A, Coleman K, Wei W, Garrett Mayer E, et al. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXR? expression in human colon cancer cells. Oncotarget. 2016;7:35313-26 pubmed 出版商
  9. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed 出版商
  10. Schaefer Klein J, Murphy S, Johnson S, Vasmatzis G, Kovtun I. Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression. PLoS ONE. 2015;10:e0142327 pubmed 出版商
  11. Yu C, Ji S, Sha Q, Sun Q, Fan H. CRL4-DCAF1 ubiquitin E3 ligase directs protein phosphatase 2A degradation to control oocyte meiotic maturation. Nat Commun. 2015;6:8017 pubmed 出版商
  12. Simpson D, Lemonie N, Morgan D, Gaddameedhi S, Kaufmann W. Oncogenic BRAF(V600E) Induces Clastogenesis and UVB Hypersensitivity. Cancers (Basel). 2015;7:1072-90 pubmed 出版商
  13. Pang B, de Jong J, Qiao X, Wessels L, Neefjes J. Chemical profiling of the genome with anti-cancer drugs defines target specificities. Nat Chem Biol. 2015;11:472-80 pubmed 出版商
  14. Zhao W, Chen R, Zhao M, Li L, Fan L, Che X. High glucose promotes gastric cancer chemoresistance in vivo and in vitro. Mol Med Rep. 2015;12:843-50 pubmed 出版商
  15. Liu Y, Ban L, Su X, Gao S, Liu J, Cui X. Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells. Mol Med Rep. 2015;12:1598-604 pubmed 出版商
  16. Rusz O, Vörös A, Varga Z, Kelemen G, Uhercsák G, Nikolényi A, et al. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer. Pathol Oncol Res. 2015;21:977-84 pubmed 出版商
  17. Voets E, Wolthuis R. MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C. Biol Open. 2015;4:484-95 pubmed 出版商
  18. El Rebey H, Aiad H, Abulkheir I, Asaad N, El Wahed M, Abulkasem F, et al. The Predictive and Prognostic Role of Topoisomerase IIα and Tissue Inhibitor of Metalloproteinases 1 Expression in Locally Advanced Breast Carcinoma of Egyptian Patients Treated With Anthracycline-based Neoadjuvant Chemotherapy. Appl Immunohistochem Mol Morphol. 2016;24:167-78 pubmed 出版商
  19. Boekhout M, Wolthuis R. Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20. J Cell Sci. 2015;128:1639-53 pubmed 出版商
  20. Kiianitsa K, Maizels N. Ultrasensitive isolation, identification and quantification of DNA-protein adducts by ELISA-based RADAR assay. Nucleic Acids Res. 2014;42:e108 pubmed 出版商
  21. Zhang H, Zhang Y, Yasukawa T, Dalla Rosa I, Khiati S, Pommier Y. Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases II? and II? in vertebrate mitochondria. Nucleic Acids Res. 2014;42:7259-67 pubmed 出版商
  22. Kiszner G, Wichmann B, Nemeth I, Varga E, Meggyeshazi N, Teleki I, et al. Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas. Virchows Arch. 2014;464:603-12 pubmed 出版商
  23. d Alcontres M, Palacios J, Mejias D, Blasco M. TopoII? prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres. Cell Cycle. 2014;13:1463-81 pubmed 出版商
  24. de Poot S, Lai K, van der Wal L, Plasman K, Van Damme P, Porter A, et al. Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 2014;21:416-26 pubmed 出版商
  25. Li W, Zhong S, Wu Y, Xu W, Xu J, Tang J, et al. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines. Mol Biol Rep. 2013;40:6143-50 pubmed
  26. Gavrilov A, Gushchanskaya E, Strelkova O, Zhironkina O, Kireev I, Iarovaia O, et al. Disclosure of a structural milieu for the proximity ligation reveals the elusive nature of an active chromatin hub. Nucleic Acids Res. 2013;41:3563-75 pubmed 出版商